Letter from Seneca Biopharma's Executive Chairman

GERMANTOWN, Md., Sept. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following let... Biopharmaceuticals Seneca Biopharma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news